Show simple item record

dc.contributor.authorKissling, Esther
dc.contributor.authorHooiveld, Mariette
dc.contributor.authorSandonis Martín, Virginia
dc.contributor.authorMartínez-Baz, Iván
dc.contributor.authorWilliam, Naoma
dc.contributor.authorVilcu, Ana-Maria
dc.contributor.authorMazagatos, Clara
dc.contributor.authorDomegan, Lisa
dc.contributor.authorde Lusignan, Simon
dc.contributor.authorMeijer, Adam
dc.contributor.authorMachado, Ausenda
dc.contributor.authorBrytting, Mia
dc.contributor.authorCasado, Itziar
dc.contributor.authorMurray, Josephine-L K
dc.contributor.authorBelhillil, Sylvie
dc.contributor.authorLarrauri, Amparo
dc.contributor.authorO'Donnell, Joan
dc.contributor.authorTsang, Ruby
dc.contributor.authorde Lange, Marit
dc.contributor.authorRodrigues, Ana Paula
dc.contributor.authorRiess, Maximilian
dc.contributor.authorCastilla, Jesús
dc.contributor.authorHamilton, Mark
dc.contributor.authorFalchi, Alessandra
dc.contributor.authorPozo, Francisco
dc.contributor.authorDunford, Linda
dc.contributor.authorCogdale, Jade
dc.contributor.authorJansen, Tessa
dc.contributor.authorGuiomar, Raquel
dc.contributor.authorEnkirch, Theresa
dc.contributor.authorBurgui, Cristina
dc.contributor.authorSigerson, Debbie
dc.contributor.authorBlanchon, Thierry
dc.contributor.authorMartínez Ochoa, Eva María
dc.contributor.authorConnell, Jeff
dc.contributor.authorEllis, Joanna
dc.contributor.authorvan Gageldonk-Lafeber, Rianne
dc.contributor.authorKislaya, Irina
dc.contributor.authorRose, Angela Mc
dc.contributor.authorValenciano, Marta
dc.date.accessioned2021-08-02T12:46:22Z
dc.date.available2021-08-02T12:46:22Z
dc.identifier.pmid34296676
dc.identifier.doi10.2807/1560-7917.ES.2021.26.29.2100670
dc.identifier.urihttp://hdl.handle.net/10029/625207
dc.language.isoenen_US
dc.subjectCOVID-19en_US
dc.subjectEuropeen_US
dc.subjectSARS-CoV-2en_US
dc.subjectmulticentre studyen_US
dc.subjecttest-negative designen_US
dc.subjectvaccine effectivenessen_US
dc.titleVaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021.en_US
dc.typeArticleen_US
dc.typeOtheren_US
dc.identifier.eissn1560-7917
dc.identifier.journalEuro Surveill 2021; 26(29):pii.2100670en_US
dc.source.journaltitleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
dc.source.volume26
dc.source.issue29
dc.source.countrySweden


This item appears in the following Collection(s)

Show simple item record